SCHEMBL5317829

SCHEMBL5317829

CC(=O)Nc1cccc(OCCCCOc2ccc3c4ccccc4n(CCC(=O)O)c3c2)c1.CCNC(=O)Cn1c2ccccc2c2ccc(OCCCCOc3cccc(C)c3)cc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.46
TP53 P04637 1/20 0.46
PSEN1 P49768 6/20 0.43
PSEN2 P49810 6/20 0.43
APH1B Q8WW43 6/20 0.43
NCSTN Q92542 6/20 0.43
APH1A Q96BI3 6/20 0.43
PSENEN Q9NZ42 6/20 0.43
HCRTR1 O43613 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
BRD4 O60885 1/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
HTT P42858 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5149421 0.88 PSEN1 (0.52) MAPTPSEN1PSEN2APH1BNCSTN
SCHEMBL5151161 0.86 MAPT (0.52) MAPTTP53PSEN1PSEN2APH1B
SCHEMBL5317028 0.85 PSEN1 (0.52) MAPTTP53PSEN1PSEN2APH1B
SCHEMBL5151224 0.83 HCRTR1 (0.56) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5149338 0.83 SMN1; SMN2 (0.50) MAPTPSEN1PSEN2APH1BNCSTN
SCHEMBL5149628 0.82 PSEN1 (0.50) MAPTPSEN1PSEN2APH1BNCSTN
SCHEMBL5317831 0.82 MAPT (0.42) MAPTTP53PSEN1PSEN2APH1B
SCHEMBL5149501 0.81 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5151343 0.81 KMT2A (0.53) MAPTPSEN1PSEN2APH1BNCSTN
SCHEMBL5149603 0.81 LMNA (0.54) MAPTPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007071456-A1 FLUORENES AND CARBAZOLES AS LIGANDS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2007-06-28 WO claimed